Nan Fung Life Sciences
Guy joined NFLS in 2021 and serves as Director of Technology, responsible for digital transformation and AI/ML initiatives. Prior to joining NFLS he was a Partner at Grove Ventures, a Deep Technology and AI-focused fund, where he invested in companies such as Wiliot and Spry Health. Previously Guy was an Executive in Residence at Tallwood Venture Capital, where he was responsible for investments in Wilocity (Acquired by Qualcomm) and Quintic (Acquired by NXP). Guy was also a founder, President and CTO at Provigent, (acquired by Broadcom) where he grew the company from inception. Guy holds a BA in Mathematics and Physics from the Hebrew University in Jerusalem and is a graduate of Talpiot, Israel’s most exclusive academic program.
This person is not in any offices
Nan Fung Life Sciences
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group’s strong capital base and long-term commitment to the area, the company is aimed to become the ideal partner for scientists, entrepreneurs, corporations, and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices, and diagnostics) and across different development stages, Nan Fung Life Sciences has a significant presence in both US and Greater China.